| Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2017: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2015: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
|
|---|
| Outline of Final Research Achievements |
To date, hypoxia-inducible factors (HIFs) have been revealed to play an important role in pathogenesis of various diseases. In this study, we generated and evaluated conditional knockout mice for HIFs and their negative regulator VHL. HIF deletion in adult retina induced no abnormal phenotype whereas ectopic HIF stabilization lead retinal degeneration indicating that HIF can be a new therapeutic target for retinal diseases. Furthermore, we administrated HIF inhibitors in animal models of retinal degeneration and confirmed a therapeutic effect against the phenotypes. These results suggested that HIF inhibition can contribute not only for retinal disease treatment but also prevention.
|
